Knowing whether a tumor is ER-positive or PR-positive helps in predicting the behavior of the tumor and its response to hormonal therapies. For instance, ER-positive breast cancers are more likely to respond to treatments like tamoxifen or aromatase inhibitors, which block the hormone's effects or decrease its production.
